175 related articles for article (PubMed ID: 38347529)
1. Molecular characterization of extensively drug-resistant hypervirulent Pseudomonas aeruginosa isolates in China.
Li J; Tang M; Liu Z; Wei Y; Xia F; Xia Y; Hu Y; Wang H; Zou M
Ann Clin Microbiol Antimicrob; 2024 Feb; 23(1):13. PubMed ID: 38347529
[TBL] [Abstract][Full Text] [Related]
2. Clinical and bacterial characteristics of Pseudomonas aeruginosa affecting the outcome of patients with bacteraemic pneumonia.
Recio R; Viedma E; González-Bodí S; Villa J; Orellana MÁ; Mancheño-Losa M; Lora-Tamayo J; Chaves F
Int J Antimicrob Agents; 2021 Dec; 58(6):106450. PubMed ID: 34644604
[TBL] [Abstract][Full Text] [Related]
3. Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.
Recio R; Villa J; Viedma E; Orellana MÁ; Lora-Tamayo J; Chaves F
Int J Antimicrob Agents; 2018 Aug; 52(2):172-179. PubMed ID: 29621591
[TBL] [Abstract][Full Text] [Related]
4. [In vitro activity of ceftazidime-avibactam combined with colistin against extensively drug-resistant Pseudomonas aeruginosa].
Mei Q; Geng S; Fang X; He Y; Liu L; Xu M; Zhu C; Pan A
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Oct; 31(10):1212-1218. PubMed ID: 31771717
[TBL] [Abstract][Full Text] [Related]
5. [Detection of Virulence Genes in Pseudomonas aeruginosa Isolates by Polymerase Chain Reaction and Investigation of High-Risk Clones by Matrix Assisted Laser Desorption/ Ionization Time-of-Flight Mass Spectrometer Method].
Karacan Temür G; Tanriverdi Çayci Y; Birinci A
Mikrobiyol Bul; 2024 Apr; 58(2):135-147. PubMed ID: 38676582
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial Activity of Ceftolozane-Tazobactam, Ceftazidime-Avibactam, and Cefiderocol against Multidrug-Resistant Pseudomonas aeruginosa Recovered at a German University Hospital.
Weber C; Schultze T; Göttig S; Kessel J; Schröder A; Tietgen M; Besier S; Burbach T; Häussler S; Wichelhaus TA; Hack D; Kempf VAJ; Hogardt M
Microbiol Spectr; 2022 Oct; 10(5):e0169722. PubMed ID: 36190424
[TBL] [Abstract][Full Text] [Related]
7. Characterization of clinical extensively drug-resistant Pseudomonas aeruginosa in the Hunan province of China.
Li J; Zou M; Dou Q; Hu Y; Wang H; Yan Q; Liu WE
Ann Clin Microbiol Antimicrob; 2016 May; 15(1):35. PubMed ID: 27215335
[TBL] [Abstract][Full Text] [Related]
8. High incidence of MDR and XDR Pseudomonas aeruginosa isolates obtained from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial.
Pérez A; Gato E; Pérez-Llarena J; Fernández-Cuenca F; Gude MJ; Oviaño M; Pachón ME; Garnacho J; González V; Pascual Á; Cisneros JM; Bou G
J Antimicrob Chemother; 2019 May; 74(5):1244-1252. PubMed ID: 30753505
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update.
Del Barrio-Tofiño E; López-Causapé C; Oliver A
Int J Antimicrob Agents; 2020 Dec; 56(6):106196. PubMed ID: 33045347
[TBL] [Abstract][Full Text] [Related]
10. Association between Pseudomonas aeruginosa O-antigen serotypes, resistance profiles and high-risk clones: results from a Spanish nationwide survey.
Del Barrio-Tofiño E; Sánchez-Diener I; Zamorano L; Cortes-Lara S; López-Causapé C; Cabot G; Bou G; Martínez-Martínez L; Oliver A;
J Antimicrob Chemother; 2019 Nov; 74(11):3217-3220. PubMed ID: 31430372
[TBL] [Abstract][Full Text] [Related]
11. Comparison of methods to analyse susceptibility of German MDR/XDR Pseudomonas aeruginosa to ceftazidime/avibactam.
Schaumburg F; Bletz S; Mellmann A; Becker K; Idelevich EA
Int J Antimicrob Agents; 2019 Aug; 54(2):255-260. PubMed ID: 31071465
[TBL] [Abstract][Full Text] [Related]
12. Characterization and genetic analysis of extensively drug-resistant hospital acquired Pseudomonas aeruginosa isolates.
Abdelaziz MA; El-Aziz AMA; El-Sokkary MMA; Barwa R
BMC Microbiol; 2024 Jun; 24(1):225. PubMed ID: 38926687
[TBL] [Abstract][Full Text] [Related]
13. Ceftazidime-avibactam and ceftolozane-tazobactam susceptibility of multidrug resistant Pseudomonas aeruginosa strains in Hungary.
O'Neall D; Juhász E; Tóth Á; Urbán E; Szabó J; Melegh S; Katona K; Kristóf K
Acta Microbiol Immunol Hung; 2020 Mar; 67(1):61-65. PubMed ID: 32208923
[TBL] [Abstract][Full Text] [Related]
14. Molecular Characterization of Extended-Spectrum Beta Lactamase- and Carbapenemase-Producing Pseudomonas aeruginosa Strains from a Malaysian Tertiary Hospital.
Phoon HYP; Hussin H; Hussain BM; Thong KL
Microb Drug Resist; 2018 Oct; 24(8):1108-1116. PubMed ID: 29437541
[TBL] [Abstract][Full Text] [Related]
15. Clonal Dissemination of Pseudomonas aeruginosa Sequence Type 235 Isolates Carrying blaIMP-6 and Emergence of blaGES-24 and blaIMP-10 on Novel Genomic Islands PAGI-15 and -16 in South Korea.
Hong JS; Yoon EJ; Lee H; Jeong SH; Lee K
Antimicrob Agents Chemother; 2016 Dec; 60(12):7216-7223. PubMed ID: 27671068
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center.
de Almeida Silva KCF; Calomino MA; Deutsch G; de Castilho SR; de Paula GR; Esper LMR; Teixeira LA
Burns; 2017 Feb; 43(1):137-143. PubMed ID: 27595453
[TBL] [Abstract][Full Text] [Related]
17. Detection of synergistic antimicrobial resistance mechanisms in clinical isolates of Pseudomonas aeruginosa from post-operative wound infections.
Awan AB; Yan A; Sarwar Y; Schierack P; Ali A
Appl Microbiol Biotechnol; 2021 Dec; 105(24):9321-9332. PubMed ID: 34797390
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of blaGES-5 and bla veb-1 genes with multidrug-resistant extend, pandrug resistance patterns (MDR, XDR, PDR), and biofilm formation in Pseudomonas aeruginosa isolates.
Ali FA; Bakir SH; Haji SH; Hussen BM
Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):52-60. PubMed ID: 34933733
[TBL] [Abstract][Full Text] [Related]
19. Co-harboring of mcr-1 and β-lactamase genes in Pseudomonas aeruginosa by high-resolution melting curve analysis (HRMA): Molecular typing of superbug strains in bloodstream infections (BSI).
Tahmasebi H; Dehbashi S; Arabestani MR
Infect Genet Evol; 2020 Nov; 85():104518. PubMed ID: 32891877
[TBL] [Abstract][Full Text] [Related]
20. Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
Del Barrio-Tofiño E; López-Causapé C; Cabot G; Rivera A; Benito N; Segura C; Montero MM; Sorlí L; Tubau F; Gómez-Zorrilla S; Tormo N; Durá-Navarro R; Viedma E; Resino-Foz E; Fernández-Martínez M; González-Rico C; Alejo-Cancho I; Martínez JA; Labayru-Echverria C; Dueñas C; Ayestarán I; Zamorano L; Martinez-Martinez L; Horcajada JP; Oliver A
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
